Could your blood predict jaw pain? new study investigates cannabinoid receptors
NCT ID NCT06405646
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study explores whether the levels of certain receptors (CB1, CB2, TRPV-1) in the blood are linked to chronic orofacial pain from jaw muscles. Researchers will compare 102 adults with and without this pain, using blood tests and clinical exams. The goal is to understand how these receptors, which bind to cannabis-like compounds, might influence pain risk and severity.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help identify biological markers for chronic orofacial pain, potentially leading to better diagnosis or targeted treatments.
- What could go wrong
- This is an observational study with only 102 participants, so results may not apply to everyone. It measures receptor levels, not treatments, so direct benefits are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OROFACIAL PAIN OF MUSCLE ORIGIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Wroclaw Medical University
Wroclaw, 50-425, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a smartphone Check-In ease chronic jaw pain?
- Do wind instruments cause more jaw pain? survey targets amateur musicians
- Can a few therapy sessions ease jaw pain and improve sleep?
- New shoulder pain guideline put to the test in GP clinics
- New tool beats massage for Post-Workout neck pain?
- Jaw pain relief for kids: study pulled before it started